These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 6582997)

  • 1. Acute anthracycline cardiotoxicity. Comparative morphologic study of three analogues.
    Taylor AL; Applefeld MM; Wiernik PH; Grochow LB; Mader LC; Bulkley BH
    Cancer; 1984 Apr; 53(8):1660-6. PubMed ID: 6582997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute adriamycin cardiotoxicity: morphologic alterations in isolated perfused rabbit heart.
    Taylor AL; Bulkley BH
    Lab Invest; 1982 Nov; 47(5):459-64. PubMed ID: 7132289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiotoxicity and comparative pharmacokinetics of six anthracyclines in the rabbit.
    Jaenke RS; Deprez-DeCampeneere D; Trouet A
    Cancer Res; 1980 Oct; 40(10):3530-6. PubMed ID: 6934026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of the model of rat isolated perfused heart for the evaluation of anthracycline cardiotoxicity and its circumvention.
    Pouna P; Bonoron-Adèle S; Gouverneur G; Tariosse L; Besse P; Robert J
    Br J Pharmacol; 1996 Apr; 117(7):1593-9. PubMed ID: 8730759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro rat myocyte cardiotoxicity model for antitumor antibiotics using adenosine triphosphate/protein ratios.
    Dorr RT; Bozak KA; Shipp NG; Hendrix M; Alberts DS; Ahmann F
    Cancer Res; 1988 Sep; 48(18):5222-7. PubMed ID: 3409247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I and II agents in cancer therapy: I. Anthracyclines and related compounds.
    Wadler S; Fuks JZ; Wiernik PH
    J Clin Pharmacol; 1986; 26(7):491-509. PubMed ID: 2944917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of three new anthracyclines and doxorubicin on the rat isolated heart.
    Chen ZM; Colombo T; Conforti L; Grazia Donelli M; Fiedorowicz RJ; Marchi S; Paolini A; Riva E; Zuanetti G; Latini R
    J Pharm Pharmacol; 1987 Nov; 39(11):947-50. PubMed ID: 2892924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative microscopic study of cardiotoxicity and skin toxicity of anthracycline analogs.
    Dantchev D; Balercia G; Bourut C; Anjo A; Maral R; Mathé G
    Biomed Pharmacother; 1984; 38(7):322-8. PubMed ID: 6240996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased sensitivity of neonatal rabbit sarcoplasmic reticulum to anthracycline cardiotoxicity.
    Burke BE; Mushlin PS; Cusack BJ; Olson SJ; Gambliel HA; Olson RD
    Cardiovasc Toxicol; 2002; 2(1):41-51. PubMed ID: 12189279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New anthracycline antibiotics and derivatives].
    Tatsuta K
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2640-52. PubMed ID: 6594977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term and short-term models for studying anthracycline cardiotoxicity and protectors.
    Robert J
    Cardiovasc Toxicol; 2007; 7(2):135-9. PubMed ID: 17652818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo antitumor efficacy and cardiotoxicity of novel anthracycline ID6105 (11-hydroxy-aclacinomycin X, Hyrubicin).
    Ryu JS; Lee HS; Hong YS; Lee JJ; Sohn UD; Kim TY
    Cancer Chemother Pharmacol; 2006 Jun; 57(6):811-8. PubMed ID: 16175393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical assessment of anthracycline cardiotoxicity in laboratory animals: predictiveness and pitfalls.
    Robert J
    Cell Biol Toxicol; 2007 Jan; 23(1):27-37. PubMed ID: 17041747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardiotoxicity of daunorubicin and aclacinomycin A in patients with acute leukemia].
    Haruyama H; Shimazaki C; Nakanishi S; Hamami T; Nisio A; Isemura T; Katsume H; Nakagawa M; Ijichi H
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):516-21. PubMed ID: 6964037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cardiotoxic study of aclacinomycin A. Subacute cardiotoxic effect of aclacinomycin A in rats (author's transl)].
    Ariji F; Shida K; Konno K; Hirano S; Hori S
    Jpn J Antibiot; 1980 Mar; 33(3):281-93. PubMed ID: 6931238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cardiooncology: Current Aspects of Prevention of Anthracycline Toxicity].
    Vasyuk YA; Shkolnik EL; Nesterov VV; Shkolnik LD; Varlan GV
    Kardiologiia; 2016 Dec; 56(12):72-79. PubMed ID: 28290807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicologic screening of daunorubicin (NSC-82151), adriamycin (NSC-123127), and their derivatives in rats.
    Zbinden G; Brändle E
    Cancer Chemother Rep; 1975; 59(4):707-15. PubMed ID: 1175165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mediation of subacute anthracycline cardiotoxicity in rabbits by cardiac histamine release.
    Bristow MR; Kantrowitz NE; Harrison WD; Minobe WA; Sageman WS; Billingham ME
    J Cardiovasc Pharmacol; 1983; 5(6):913-9. PubMed ID: 6196562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anthracycline cardiomyopathy monitored by morphologic changes.
    Billingham ME; Mason JW; Bristow MR; Daniels JR
    Cancer Treat Rep; 1978 Jun; 62(6):865-72. PubMed ID: 667860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anthracycline cardiotoxicity in long-term survivors of childhood cancer.
    Scully RE; Lipshultz SE
    Cardiovasc Toxicol; 2007; 7(2):122-8. PubMed ID: 17652816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.